Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1820835

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1820835

China Orthobiologics Market Outlook to 2033 - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators and Others

PUBLISHED:
PAGES: 51 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "China Orthobiologics Market Outlook to 2033" is a comprehensive databook report, covering key market data on the China Orthobiologics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cartilage Repair, Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation

The China Orthobiologics Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share data for Orthobiologics Market.
  • Global corporate-level profiles of key companies operating within the China Orthobiologics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Orthobiologics is segmented as follows -

  • Cartilage Repair
  • Bone Grafts and Substitutes
  • Bone Growth Stimulators
  • Soft Tissue Biologics
  • Viscosupplementation

Reasons to Buy

The China Orthobiologics Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Product Code: GDME25767CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Orthobiologics Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Orthobiologics Market, China

  • 3.1 Orthobiologics Market, China, Revenue ($m), 2018-2033
    • 3.1.1 Bone Grafts and Substitutes Market, China, Revenue ($m), by Segment, 2018-2033
    • 3.1.2 Bone Growth Stimulators Market, China, Revenue ($m), by Segment, 2018-2033
    • 3.1.3 Cartilage Repair Market, China, Revenue ($m), by Segment, 2018-2033
    • 3.1.4 Soft Tissue Biologics Market, China, Revenue ($m), by Segment, 2018-2033
    • 3.1.5 Viscosupplementation Market, China, Revenue ($m), by Segment, 2018-2033
  • 3.2 Orthobiologics Market, China, Volume (Units), 2018-2033
    • 3.2.1 Bone Grafts and Substitutes Market, China, Volume (Units), by Segment, 2018-2033
    • 3.2.2 Bone Growth Stimulators Market, China, Volume (Units), by Segment, 2018-2033
    • 3.2.3 Cartilage Repair Market, China, Volume (Units), by Segment, 2018-2033
    • 3.2.4 Soft Tissue Biologics Market, China, Volume (Units), by Segment, 2018-2033
    • 3.2.5 Viscosupplementation Market, China, Volume (Units), by Segment, 2018-2033
  • 3.3 Orthobiologics Market, China, Average Price ($), 2018-2033
  • 3.4 Orthobiologics Market, China, Company Share by Revenue ($m), 2024

4 Overview of Key Companies in China, Orthobiologics Market

  • 4.1 Medtronic Plc
    • 4.1.1 Company Overview
  • 4.2 Sanofi
    • 4.2.1 Company Overview
  • 4.3 Stryker Corp
    • 4.3.1 Company Overview
  • 4.4 Zimmer Biomet Holdings Inc
    • 4.4.1 Company Overview
  • 4.5 Bioventus Inc
    • 4.5.1 Company Overview
  • 4.6 Seikagaku Corp
    • 4.6.1 Company Overview
  • 4.7 Orthofix Medical Inc
    • 4.7.1 Company Overview

5 Orthobiologics Market Pipeline Products

6 Recent Developments

  • 6.1 Financial Announcements
    • 6.1.1 Apr 16, 2025: Assure Tech (Hangzhou) Receives CLIA Approval for FaStep Multi-Drug Urine Test Panel
  • 6.2 Legal And Regulatory
    • 6.2.1 Apr 15, 2025: Hangzhou SHINING3D Dental Technology Receives 510(K) Clearance For DT20 Denture Base Resin
  • 6.3 Product News
    • 6.3.1 Apr 23, 2025: Assure Tech Receives CLIA Approval for Healcare Panel Dip Test

7 Appendix

  • 7.1 Research Methodology
    • 7.1.1 Coverage
    • 7.1.2 Secondary Research
    • 7.1.3 Primary Research
    • 7.1.4 Market Modeling and Forecasting
    • 7.1.5 Company Share Analysis
    • 7.1.6 Benchmarking
  • 7.2 GlobalData Consulting
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME25767CCDB

List of Table

List of Tables

  • Table 1: Orthobiologics Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 4: Cartilage Repair Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 5: Soft Tissue Biologics Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 6: Viscosupplementation Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 7: Orthobiologics Market, China, Volume (Units), 2018-2033
  • Table 8: Bone Grafts and Substitutes Market, China, Volume (Units), 2018-2033
  • Table 9: Bone Growth Stimulators Market, China, Volume (Units), 2018-2033
  • Table 10: Cartilage Repair Market, China, Volume (Units), 2018-2033
  • Table 11: Soft Tissue Biologics Market, China, Volume (Units), 2018-2033
  • Table 12: Viscosupplementation Market, China, Volume (Units), 2018-2033
  • Table 13: Orthobiologics Market, China, Average Price ($), 2018-2033
  • Table 14: Orthobiologics Market, China, Company Share by Revenue ($m), 2024
  • Table 15: Orthobiologics Market Pipeline Products
  • Table 16: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figure

List of Figures

  • Figure 1: Orthobiologics Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 4: Cartilage Repair Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: Soft Tissue Biologics Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 6: Viscosupplementation Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 7: Orthobiologics Market, China, Volume (Units), 2018-2033
  • Figure 8: Bone Grafts and Substitutes Market, China, Volume (Units), 2018-2033
  • Figure 9: Bone Growth Stimulators Market, China, Volume (Units), 2018-2033
  • Figure 10: Cartilage Repair Market, China, Volume (Units), 2018-2033
  • Figure 11: Soft Tissue Biologics Market, China, Volume (Units), 2018-2033
  • Figure 12: Viscosupplementation Market, China, Volume (Units), 2018-2033
  • Figure 13: Orthobiologics Market, China, Company Share (%), 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!